Cyclopharm Limited (ASX:CYC)
Australia · Delayed Price · Currency is AUD 0.9200
-0.0100 (-1.08%)
Feb 11, 2026, 10:36 AM AEST
Cyclopharm Company Description
Cyclopharm Limited manufacture and sells medical equipment and radiopharmaceuticals in the Asia Pacific, Europe, Canada, the United States, and internationally.
The company operates Technegas which offers diagnostic equipment and consumables used by physicians in the detection of pulmonary embolism and other respiratory conditions.
It is also involved in the research and development; and distribution of third-party products to the diagnostic imaging sector.
The company serves nuclear medicine departments. Cyclopharm Limited was founded in 1986 and is headquartered in Kingsgrove, Australia.
Cyclopharm Limited
| Country | Australia |
| Founded | 1986 |
| Industry | Medical Distribution |
| Sector | Healthcare |
| Employees | 97 |
| CEO | James McBrayer |
Contact Details
Address: 1 The Crescent Kingsgrove, NSW 2208 Australia | |
| Phone | 61 2 9541 0411 |
| Website | cyclomedica.com |
Stock Details
| Ticker Symbol | CYC |
| Exchange | Australian Securities Exchange |
| Fiscal Year | January - December |
| Reporting Currency | AUD |
| ISIN Number | AU000000CYC5 |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| James S. McBrayer AIM, BSPharm, F.A.C.I.D., FAICD, GDM | Chief Executive Officer, MD, Company Secretary and Director |
| Jason Smith | Chief Financial Officer |
| Mathew Farag | Chief Operating Officer |
| Sally-Ann Cornelius | Head of Sales |
| Niamh McAree | Head of Quality and Regulatory |
| Chris Quinn | Head of Service |
| Sui Ling Cheah | Financial Controller |
| Lynn McLauchlin | General Manager of Canada |
| Gary T. Somerville | Quality and Regulatory Manager |